Detecting endometrial and ovarian cancer with the Pap-smear
- Conditions
- Endometrial cancerOvarian cancerEndometriumcarcinoomOvariumcarcinoomEierstokkankerBaarmoederslijmvlieskankerPap-smearUitstrijkje
- Registration Number
- NL-OMON22188
- Lead Sponsor
- Radboud university medical center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Endometrial cancer: all patients presenting with preoperative diagnosis of endometrial cancer (via pipelle endometrial biopsy or dilatation and curettage).
Ovarian cancer: all patients scheduled for surgery for suspected ovarian cancer (RMI>200, ascites).
Exclusion Criteria
Patients who received pelvic radiation in the past and patients with ovarian cancer who do not have a uterus will not be able to participate in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of the Pap-smear in detecting endometrial and ovarian cancer
- Secondary Outcome Measures
Name Time Method The sensitivity and specificity of the cervicovaginal self-sample and the Pipelle endometrial biopsy in detecting endometrial and ovarian cancer.<br /><br>The correlation between DNA alterations in the cervicovaginal self-sample, the Pap-smear and the Pipelle endometrial biopsy and clinicopathologic parameters